Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study.
Cortes J, Di Cosimo S, Climent MA, Cortés-Funes H, Lluch A, Gascón P, Mayordomo JI, Gil M, Benavides M, Cirera L, Ojeda B, Rodríguez CA, Trigo JM, Vazquez J, Regueiro P, Dorado JF, Baselga J; Spanish Breast Cancer Cooperative Group SOLTI. Cortes J, et al. Among authors: cirera l. Clin Cancer Res. 2009 Jan 1;15(1):307-14. doi: 10.1158/1078-0432.CCR-08-1113. Clin Cancer Res. 2009. PMID: 19118059 Clinical Trial.
Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
Nogué M, Salud A, Batiste-Alentorn E, Saigí E, Losa F, Cirera L, Méndez M, Campos JM, Galan A, Escudero P, Arcusa A, Manzano H, de Mendizábal EV, de Olaguer JP, Boleda M, Guasch I, Vicente P. Nogué M, et al. Among authors: cirera l. Eur J Cancer. 2005 Oct;41(15):2241-9. doi: 10.1016/j.ejca.2005.07.013. Eur J Cancer. 2005. PMID: 16214045 Clinical Trial.
Pharmacogenetic clinical randomised phase II trial to evaluate the efficacy and safety of FOLFIRI with high-dose irinotecan (HD-FOLFIRI) in metastatic colorectal cancer patients according to their UGT1A 1 genotype.
Páez D, Tobeña M, Fernández-Plana J, Sebio A, Virgili AC, Cirera L, Barnadas A, Riera P, Sullivan I, Salazar J. Páez D, et al. Among authors: cirera l. Br J Cancer. 2019 Jan;120(2):190-195. doi: 10.1038/s41416-018-0348-7. Epub 2018 Dec 26. Br J Cancer. 2019. PMID: 30585257 Free PMC article. Clinical Trial.
Differential patterns of recurrence and specific survival between luminal A and luminal B breast cancer according to recent changes in the 2013 St Gallen immunohistochemical classification.
García Fernández A, Chabrera C, García Font M, Fraile M, Lain JM, Gónzalez S, Barco I, González C, Torres J, Piqueras M, Cirera L, Veloso E, Pessarrodona A, Giménez N. García Fernández A, et al. Among authors: cirera l. Clin Transl Oncol. 2015 Mar;17(3):238-46. doi: 10.1007/s12094-014-1220-8. Epub 2014 Oct 1. Clin Transl Oncol. 2015. PMID: 25270605
Differential survival and recurrence patterns of patients operated for breast cancer according to the new immunohistochemical classification: analytical survey from 1997 to 2012.
García Fernández A, Chabrera C, García Font M, Fraile M, Gónzalez S, Barco I, González C, Cirera L, Veloso E, Lain JM, Pessarrodona A, Giménez N. García Fernández A, et al. Among authors: cirera l. Tumour Biol. 2013 Aug;34(4):2349-55. doi: 10.1007/s13277-013-0782-3. Epub 2013 Apr 19. Tumour Biol. 2013. PMID: 23605321
A study comparing two consecutive historical periods in breast cancer with a focus on surgical treatment, loco-regional recurrence, distant metastases and mortality.
García-Fernández A, Chabrera C, García-Font M, Fraile M, Barco I, González S, Cirera L, Lain JM, González C, Veloso E, Codina L, Piqueras M, Pessarrodona A, Gimenez N. García-Fernández A, et al. Among authors: cirera l. Clin Transl Oncol. 2015 Apr;17(4):296-305. doi: 10.1007/s12094-014-1227-1. Epub 2014 Oct 1. Clin Transl Oncol. 2015. PMID: 25270606
97 results